CIDRAP newsletters options
The review recommends investment in innovative manufacturing and greater FDA authority.
PAHO's head notes two worlds: "One quickly returning to normal, and another where recovery remains a distant future."
A study of adults with intellectual and developmental disabilities (IDD) living in New York City group homes has identified older age, larger residential settings, Down syndrome, and chronic kidney disease as risk factors for COVID-19 infection, with heart disease as a risk factor for related death.
Automated software that simulates people is the primary driver of COVID-19 misinformation, a study finds.
New CDC data show that COVID-19 vaccines have been particularly beneficial for older Americans.
New data show no adverse outcomes in infants exposed to the flu vaccine in utero.
A survey of 164 New York physicians found that one in five were severely distressed during their first COVID-19 triage decisions and last-minute training did not appear to alleviate stress, according to a study yesterday in Disaster Medicine and Public Health Preparedness.
CARB-X announced today that is awarding Tucson, Arizona–based Accelerate Diagnostics $578,000 to develop a diagnostic test for sepsis based on new fiber optic technology.
Two studies look at pediatric COVID-19 hospitalizations in the United States and Brazil.
Dutch travelers to Asia, Africa acquired 56 unique antimicrobial-resistance genes.
Some Asian countries, like Taiwan, continue to battle stubborn COVID spikes.
The slowdown is nationwide, but states in the South and Midwest report plummeting numbers.
The use of rapid respiratory pathogen (RRP) testing among children with influenza-like illness (ILI) did not reduce antibiotic prescribing, according to a randomized clinical trial published late last week in JAMA Network Open.
In a population study of 13- to 18-year-old Icelandic teens, mental health worsened during the COVID-19 pandemic, according to a study late last week in The Lancet Psychiatry.
Pressure grows on wealthy countries that have excess doses to start donating them.
One study suggests that symptoms like fatigue and depression are common, even with mild illness.
Most states will not have 70% of adults vaccinated against COVID-19 by Jul 4, an analysis finds.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Nearly 80% of US patients hospitalized for COVID-19 received antibiotics from March through October 2020, researchers from the Centers for Disease Control and Prevention (CDC) reported yesterday in Open Forum Infectious Diseases.
Preventive use of bamlanivimab lowered the risk of symptomatic COVID-19 in staff and residents of skilled nursing and assisted living facilities in the United States, according to a study yesterday in JAMA.
